When you work through a telehealth-first platform, you have the benefit of ongoing support without the need for frequent in-person visits
However, some patients with both Hashimoto's and obesity or type 2 diabetes explore GLP-1 medications for metabolic benefits while managing thyroid condition in parallel
Je tie mon, e vae osobn daje zskavame nepriamo prostrednctvom tretch osb
These medications are prepared by licensed 503A pharmacies in accordance with the Federal Food, Drug, and Cosmetic Act
doi:10.1210/jc.2003-030738 38
#LifeSciences #Pharma #DrugDelivery #GLP1 #LEXX #BiotechInvesting Lexaria CEO on DehydraTECH and Oral GLP-1s To view or add a comment, sign in Zacks SCR Senior Life Sciences Analyst, John Vandermosten, speaks with Lexaria Bioscience (NASDAQ: LEXX) CEO Rich Christopher about the companys DehydraTECH platform and its potential to transform GLP-1 drug delivery